T. Strassner et al.
FULL PAPERS
or a highly viscous substance. After diluting the reaction mixture with
400 mL methanol, 32.1 g ammonium chloride and 48 mL formaldehyde
solution (37% in water) are added. The reaction mixture is heated under
reflux for 1 h and the resulting dark solution is allowed to cool down and
is mixed with 14 mL phosphoric acid. Finally, the reaction mixture is
heated for 4 h under reflux. 2/3 of the solvent is removed by evaporation
under reduced pressure, and the resulting crude solution is mixed with
200–300 mL ice water. Potassium hydroxide solution (40%) is added
until pH 9 is reached. The aqueous phase is extracted 4 times with di-
chloromethane and the combined organic phases are washed with water,
saturated sodium chloride solution, and dried over magnesium sulphate.
To isolate the crude product, the solvent is removed under reduced pres-
sure after filtration. The product is either purified by Kugelrohr distilla-
tion or recrystallization from ethyl acetate.
1-(4-(ethoxycarbonyl)phenyl)-3-heptyl-1H-imidazolium bromide 36a
Following the general synthetic procedure, 4.60 mmol (1.00 g) ethyl 4-
(1H-imidazol-1-yl)benzoate, and 5.50 mmol (0.99 g) 1-bromoheptane are
dissolved in THF and heated for 20 h at 958C. Yield: 1.14 g (62%); m.p.:
1128C; 1H NMR (300 MHz, [D6]DMSO, 258C): d=0.89 (m, 3H; CH3),
1.32 (m, 8H, 4xCH2), 1.37 (t, 3JH,H =7.4 Hz, 3H, CH3), 1.90 (m, 2H,
CH2), 4.26 (t, 3JH,H =7.4 Hz, 2H, NCH2), 4.38 (q, 2H, 3JH,H =7.4 Hz,
OCH2), 7.97 (d, 3JH,H =8.7 Hz, 2H, ArH), 8.10 (s, 1H, NCHCHN), 8.22
(d, 3JH,H =8.7 Hz, 2H, ArH), 8.44 (s, 1H, NCHCHN), 9.96 ppm (s, 1H,
NCHN); 13C NMR (125.8 MHz, [D6]DMSO, 258C): d=13.9, 14.1, 21.9,
25.5, 28.1, 29. 1, 31.0, 49.5, 61.3, 120.9, 121.9, 123.5, 130.7, 130.9, 135.8,
138.1, 164.6 ppm; elemental analysis: calcd. (%) for C19H27BrN2O2:
C 57.72, H 6.88, N 7.09; found: C 57.37, H 6.96, N 7.06.
1-(4-(ethoxycarbonyl)phenyl)-3-tetradecyl-1H-imidazolium bromide 44a
Ethyl 4-(1H-imidazol-1-yl)benzoate 12
Following the general synthetic procedure, 4.60 mmol (1.00 g) ethyl 4-
(1H-imidazol-1-yl)benzoate, and 5.50 mmol (1.50 g) 1-bromotetradecane
are dissolved in tetrahydrofuran and heated for 20 h at 958C. Yield:
1.40 g (61%); m.p.: 1268C; 1H NMR (300 MHz, [D6]DMSO, 258C): d=
Following the general synthetic procedure, 0.1 mol ethyl-4-aminoben-
zoate is used. The resulting product is recrystallized from 20 mL ethyl
acetate to give
a
solid product. Yield: 15.93 g (74%); 1H NMR
(300 MHz, [D6]DMSO, 258C): d=1.37 (t, 3JH,H =7.1 Hz, 3H, CH3), 4.36
(q, 3JH,H =7.1 Hz, 2H, CH2), 7.18 (s, 1H, NCHCHN), 7.31 (s, 1H,
NCHCHN), 7.42 (d, 3JH,H =8.7 Hz, 2H, ArH), 7.90 (s, 1H, NCHN),
8.11 ppm (d, 3JH,H =8.7 Hz, 2H, ArH); 13C NMR (125.8 MHz,
[D6]DMSO, 258C): d=14.2, 61.1, 117.6, 120.4, 129.2, 130.9, 131.2, 135.3,
140.5, 165.3 ppm; elemental analysis: calcd (%) for C12H12N2O2 (216.24):
C 66.65, H 5.59, N 12.96; found: C 66.42, H 5.54, N 12.57.
0.85 (t, 3JH,H =6.9 Hz, 3H, CH2CH2CH3), 1.27 (m, 22H, alkyl CH2), 1.40
À
(t, 3JH,H =7.1 Hz, 3H, OCH2CH3), 1.93 (m, 2H, NCH2CH2), 4.25 (t,
3JH,H =7.3 Hz, 2H, NCH2), 4.39 (q, 3JH,H =7.1 Hz, 2H; OCH2), 7.97 (d,
3JH,H =8.8 Hz, 2H, ArH), 8.10 (s, 1H, NCHCHN), 8.23 (d, 3JH,H =8.8 Hz,
2H, ArH), 8.45 (s, 1H, NCHCHN), 9.96 ppm (s, 1H, NCHN); 13C NMR
(125.8 MHz, [D6]DMSO, 258C): d=13.9, 14.1, 22.1, 25.5, 28.4, 28.7, 28.8,
28.9, 29.0, 29.0, 31.3, 49.5, 61.3, 120.9, 121.9, 123.5, 130.7, 131.0, 135.8,
138.1, 164.6 ppm; elemental analysis: calcd. (%) for C26H41BrN2O2:
C 63.28, H 8.37, N 5.68; found: C 63.28, H 8.42, N 5.76.
The synthetic procedures and analytical characterizations of compounds
9–16 are given in the Supporting Information.
Preparation of the Imidazolium Bromides
A detailed description of the preparation and analytical characterization
for all bromide salts 17a–48a is given in the Supporting Information.
Alkylation of the 1-N-substituted imidazoles is carried out in an ACE
pressure tube, within a temperature range of 80–1108C. 1 Equivalent of
the substituted imidazole derivative is dissolved in 10 mL tetrahydrofuran
and a slight excess (1.1 equiv) of the bromoalkane is added. The reaction
mixture is heated for 8 to 10 hours. By washing with tetrahydrofuran the
resulting crude product is purified and dried under vacuum.
Preparation of the Corresponding Bis(trifluoromethanesulfonyl)imides
After completely dissolving 1 equivalent of imidazolium bromide in
water, or, for the longer alkyl chains,
a water/methanol mixture,
1.1 equivalents of lithium bis(trifluoromethansulfonyl)imide is added.
This leads to a biphasic system where dichloromethane is added for
better phase separation. The organic phase is separated from the aqueous
phase by a separatory funnel and the aqueous phase is washed twice with
dichloromethane. The combined organic phases are dried over MgSO4,
filtered, and evaporated in a rotary evaporator under vacuum. The result-
ing ionic liquid is dried under vacuum.
1-(4-(Ethoxycarbonyl)phenyl)-3-propyl-1H-imidazolium bromide 20a
Following the general synthetic procedure, 4.6 mmol (1.00 g) ethyl 4-(1H-
imidazol-1-yl)benzoate, and 5.5 mmol (0.68 g) 1-bromopropane are dis-
solved in THF and heated for 20 h at 958C. Yield: 0.838 g (52%); m.p.:
1
3
1798C; H NMR (300 MHz, [D6]DMSO, 258C): d=0.97 (t, JH,H =7.3 Hz,
3H, CH2CH2CH3), 1.42 (t, 3JH,H =7.3 Hz, 3H, OCH2CH3), 1.99 (hept,
1-(4-(Ethoxycarbonyl)phenyl)-3-propyl-1H-imidazolium
bis(trifluoromethanesulfonyl) imide 20b
3JH,H =7.3 Hz, 2H, NCH2CH2), 4.25 (t, JH,H =7.3 Hz, 2H, NCH2), 4.72 (q,
3
3JH,H =7.1 Hz, 2H, OCH2), 8.00 (d, 3JH,H =8.8 Hz, 2H, ArH), 8.12 (s, 1H,
NCHCHN), 8.25 (d, 3JH,H =8.8 Hz, 2H, ArH), 8.48 (s, 1H, NCHCHN),
10.02 ppm (s, 1H, NCHN); 13C NMR (125.8 MHz, [D6]DMSO, 258C):
d=10.5, 14.1, 22.6, 51.0, 61.3, 121.0, 121.9, 123.5, 130.7, 131.0, 135.8,
Following the general synthetic procedure, 1.47 mmol (0.50 g) 1-(4-ethox-
ycarbonyl-phenyl)-3-propyl-1H-imidazolium bromide and 1.64 mmol
(0.47 g) lithium bis(trifluoromethane-sulfonyl)imide are dissolved in a bi-
phasic system consisting of 50 mL water/20 mL dichloromethane and
stirred at room temperature. Yield: 0.73 g (92%); m.p.: 678C; 1H NMR
138.1,
164.6 ppm;
elemental
analysis:
calcd
(%)
for
C15H19BrN2O2·0.35H2O: C 52.14, H 5.75, N 8.11; found: C 52.19, H 5.79,
N 8.11.
(300 MHz, [D6]DMSO, 258C): d=0.98 (t, 3JH,H =7.3 Hz, 3H, CH3), 1.98
3
(hept, 2H, CH2), 4.23 (t, 3JH,H =7.3 Hz, 2H, NCH2), 4.48 (q, JH,H
=
1-(4-(Ethoxycarbonyl)phenyl)-3-hexyl-1H-imidazolium bromide 28a
7.1 Hz, 2H, CH2), 8.00 (d, 3JH,H =8.8 Hz, 2H, ArH), 8.11 (s, 1H,
NCHCHN), 8.27 (d, 3JH,H =8.8 Hz, 2H; ArH), 8.48 (s, 1H, NCHCHN),
9.99 ppm (s, 1H, NCHCHN), 13C NMR (125.8 MHz, [D6]DMSO, 258C):
d=10.5, 14.1, 22.6, 51.0, 61.3, 119.5, 121.0, 121.6, 123.5, 130.7, 131.0,
135.8, 164.6 ppm; elemental analysis: calcd (%) for C17H19F6N3O6S2:
C 37.85, H 3.55, N 7.79, S 11.89; found C 38.07, H 3.20, N 7.92, S 11.74.
Following the general synthetic procedure, 1.62 mmol (0.35 g) ethyl 4-
(1H-imidazol-1-yl)benzoate, and 1.78 mmol (0.294 g) 1-bromohexane are
dissolved in THF and heated for 20 h at 958C. Yield: 0.417 g (68%);
m.p.: 1138C; 1H NMR (300 MHz, [D6]DMSO, 258C): d=0.89 (m, 3H,
CH3), 1.32 (m, 6H, 3xCH2), 1.37 (t, 3JH,H =7.4 Hz, 3H, CH3), 1.90 (m,
3
3
2H, CH2), 4.26 (t, JH,H =7.4 Hz, 2H, N-CH2), 4.38 (q, JH,H =7.4 Hz, 2H,
OCH2), 7.97 (d, 3JH,H =8.7 Hz, 2H, ArH), 8.10 (s, 1H, NCHCHN), 8.22
(d, 3JH,H =8.7 Hz, 2H, ArH), 8.44 (s, 1H, NCHCHN), 9.97 ppm (s, 1H,
NCHCHN); 13C NMR (125.8 MHz, [D6]DMSO, 258C): d=13.9, 14.1,
21.9, 25.2, 29.0, 30.6, 49.5, 61.3, 120.9, 121.9, 123.5, 130.7, 130.9, 135.8,
138.1, 164.6 ppm; elemental analysis: calcd. (%) for C18H25BrN2O2:
C 56.70, H 6.61, N 7.35; found: C 56.48, H 6.67, N 7.25.
A detailed description of the preparation and analytical characterization
for all bis(trifluoromethanesulfonyl)imide salts 17b–48b is given in the
Supporting Information.
Computational Details
Density functional (DFT) calculations were carried out on the 1-aryl-3-
propyl-imidazolium cations of the prepared imidazolium salts. Geometry
optimizations of the structures were performed using the B3LYP hybrid
density functional combined with the split valence triple-z (TZ) basis set
6–311++GACTHNUTRGNEUNG
(d,p).[38–42] No symmetry or internal coordinate constraints
866
ꢁ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Asian J. 2011, 6, 863 – 867